Association of circulating cytokine and angiogenic factors (CAFs) with outcomes to second-line FOLFOX plus bevacizumab or cediranib in metastatic colorectal cancer. Methods: The key eligibility ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results